| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Bonney Michael W is a Director at DNTH with holdings across 5 companies. Recent SEC Form 4 filings include 5 buys and 23 sells.
Estimated insider holdings value: $27.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2025 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 11,250 | $450.00 | $5,062,500.00 | -40.1% | +0.8% | - | |
| May 15, 2025 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 11,250 | $277.71 | $3,124,216.94 | -3.4% | +52.6% | - | |
| Dec 27, 2023 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 30,000 | $195.00 | $5,850,000.00 | -65.2% | -22.7% | +23.4% | |
| Aug 3, 2023 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 6,448 | $185.38 | $1,195,310.07 | -4.6% | -17.4% | +43.1% | |
| Dec 4, 2019 | BMY Bristol Myers Squibb Co | Director | Buy | 88 | $58.90 | $5,183.20 | +1.2% | - | - | |
| Sep 9, 2019 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 2,000 | $86.74 | $173,480.00 | +39.6% | - | - | |
| Mar 9, 2016 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Buy | 2,000 | $58.36 | $116,720.00 | +100.0% | - | - | |
| Aug 17, 2015 | THW Abrdn World Healthcare Fund | Director | Buy | 10,917 | $18.35 | $200,294.20 | New | - | - | |
| May 12, 2015 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Buy | 2,000 | $112.16 | $224,320.00 | New | - | - |